Results 141 to 150 of about 1,515,099 (315)

2018 Update on Intravitreal Injections: Euretina Expert Consensus Recommendations

Ophthalmologica, 2018
A. Grzybowski, R. Told, S. Sacu, F. Bandello, E. Moisseiev, A. Loewenstein, U. Schmidt-Erfurth   +6 more
semanticscholar   +1 more source

Microglial Deletion of Hrh4 Alleviates Alzheimer's Disease Pathologies by Enhancing Microglial Phagocytosis of Amyloid‐β and Tau

Advanced Science, Volume 13, Issue 2, 9 January 2026.
Histamine H4 receptor (H4R) antagonist VUF6002 mimics low‐dose X‐ray irradiation in aged Alzheimer's disease (AD) mice, enhancing microglial clearance of amyloid‐beta/hyperphosphorylated tau aggregates and restoring cognition. Microglial H4R deletion activates cAMP/TGF‐β1/Smad3 pathway, enhancing phagocytosis, while TGF‐β receptor 1 deletion abolishes ...
Yi‐Jun Xu, Tan Wu, Larry Tso‐Lun Lo, Chi‐Chiu Ko, Xin Wang, Chi Him Eddie Ma   +5 more
wiley   +1 more source

Intravitreal vs. Subtenon Triamcinolone Acetonide Injection as Adjunctive for Retinal Photocoagulation in Diabetic Macular Edema [PDF]

Namir Mahmoud, Mohammed Abouelwafa, Mahmoud Namir, Mohammed   +3 more
openalex   +1 more source

Outcome of intravitreal Avastin® injections in patients with macular oedema in Uganda: a cohort study [PDF]

, 2022
Rachel R. Kabunga, John Onyango, Sam Ruvuma, Simon Arunga   +3 more
openalex   +1 more source

TSHR‐Targeting Nucleic Acid Aptamer Treats Graves' Ophthalmopathy via Novel Allosteric Inhibition

Advanced Science, Volume 13, Issue 4, 19 January 2026.
This study presents YC3, a novel inhibitory TSHR‐targeting aptamer, as a promising therapeutic for Graves' ophthalmopathy (GO). YC3 suppresses pathological phenotypes in human orbital fibroblasts and improves outcomes in GO mice by binding to a previously unidentified allosteric site on TSHR, demonstrating the potential of aptamers in advancing ...
Yanchen Zhang, Ende Wu, Weibin Liu, Ling Zeng, Neng Ling, Hongmei Wang, Zhixing Li, Shuang Yao, Tonghe Pan, Xuanwen Li, Yate Huang, Xiaojing Li, Yunhai Tu, Wentao Yan, Jianzhang Wu, Mao Ye, Wencan Wu   +16 more
wiley   +1 more source

Vancomycin‐Functionalized Nanodelivery Systems for Antibacterial Tissue Engineering Scaffolds

Advanced NanoBiomed Research, Volume 6, Issue 1, January 2026.
This review consolidates recent advancements in VAN nanoformulations, critically evaluating their design principles, release mechanisms, and efficacy profiles against resistant Gram‐positive pathogens. While promising in vitro and in vivo results have been demonstrated, the clinicaltranslation of these technologies necessitates further rigorous ...
Nima Beheshtizadeh, Mahsa Mohammadzadeh, Amir Abbas Seraji, Ali Pirsadeghi, Elham Zendedel, Maliheh Gharibshahian   +5 more
wiley   +1 more source

Intravitreal Injection of Triamcinolone [PDF]

, 2004
Michael S. Ip
openalex   +1 more source

Development and Characterization of a Noncovalent Stimulator of Interferon Genes Proteolysis‐Targeting Chimeras

ChemMedChem, Volume 21, Issue 1, January 2026.
The design, synthesis, and initial biological evaluation of noncovalent stimulator of interferon genes degraders are presented. The lead from this series, BH690L, exhibits an effective concentration for half‐maximal degradation (DC50) of 11.3 nM and a maximum level of degradation (Dmax) of 0.67.
Bo Hu, Adam S. Duerfeldt
wiley   +1 more source

Quality of Life and Treatment Satisfaction in Patients Receiving Intravitreal Injection Therapy for Neovascular Age-Related Macular Degeneration, Diabetic Macular Edema, and Retinal Vein Occlusion: A Cross-Sectional Study [PDF]

Konstantinos Flindris, Chrysa Chatzipetrou, Eleni Papafotiou, Athanasios Kaliardas, Ioannis Koumpoulis, Ioannis Melissourgos   +5 more
openalex   +1 more source

Factors associated with pain during intravitreal injection of anti-vascular endothelial growth factor [PDF]

, 2018
Ngoc Chau Isabelle Nguyen, Filippo Fabro, Aude Ambresin, Sakina Ezziat, Ciara Bergin, Claudia Mazzocato, Irmela Mantel   +6 more
openalex   +1 more source